Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Premera Blue Cross	15.01.026 Testing for Vector-Borne InfectionsPayerPolicy · PREMERA-15-01-026-TESTING-FOR-VECTOR-BORNE-INFECTIONS-5BC88E1F83	New policy
Aug 2, 2026	Premera Blue Cross	15.01.022 Nerve Fiber Density TestingPayerPolicy · PREMERA-15-01-022-NERVE-FIBER-DENSITY-TESTING-549C3AC18D	New policy
Aug 2, 2026	Premera Blue Cross	15.01.016 Identification of Microorganisms using Nucleic AcidPayerPolicy · PREMERA-15-01-016-IDENTIFICATION-OF-MICROORGANISMS-USING-NUCLEIC-ACI-F7072D2563	New policy
Aug 2, 2026	Premera Blue Cross	1.01.539 Oscillatory Devices for the Treatment of Cystic FibrosisPayerPolicy · PREMERA-1-01-539-OSCILLATORY-DEVICES-FOR-THE-TREATMENT-OF-CYSTIC-FIB-EE428F0BEF	New policy
Aug 2, 2026	Premera Blue Cross	1.01.530 Children's Therapeutic Positioning EquipmentPayerPolicy · PREMERA-1-01-530-CHILDREN-S-THERAPEUTIC-POSITIONING-EQUIPMENT-0CD2BF621E	New policy
Aug 2, 2026	Premera Blue Cross	3.03.07 Audio-Visual Neuromodulation for Neuropathic PainPayerPolicy · PREMERA-3-03-07-AUDIO-VISUAL-NEUROMODULATION-FOR-NEUROPATHIC-PAIN-A49C5BCBF3	New policy
Aug 2, 2026	Premera Blue Cross	5.01.662 Antiemetic MedicationsPayerPolicy · PREMERA-5-01-662-ANTIEMETIC-MEDICATIONS-8AF19A513F	New policy
Aug 2, 2026	Premera Blue Cross	5.01.634 Gene Therapies for Cerebral AdrenoleukodystrophyPayerPolicy · PREMERA-5-01-634-GENE-THERAPIES-FOR-CEREBRAL-ADRENOLEUKODYSTROPHY-C86255E5F9	New policy
Aug 2, 2026	Premera Blue Cross	5.01.632 Pharmacologic Treatment of Bladder CancerPayerPolicy · PREMERA-5-01-632-PHARMACOLOGIC-TREATMENT-OF-BLADDER-CANCER-8507C04057	New policy
Aug 2, 2026	Premera Blue Cross	5.01.621 Drugs for Weight ManagementPayerPolicy · PREMERA-5-01-621-DRUGS-FOR-WEIGHT-MANAGEMENT-2DAA4E6A57	New policy
Aug 2, 2026	Premera Blue Cross	5.01.593 Pharmacologic Treatment of Transthyretin-Mediated AmyloidosisPayerPolicy · PREMERA-5-01-593-PHARMACOLOGIC-TREATMENT-OF-TRANSTHYRETIN-MEDIATED-A-EC95D9CEAD	New policy
Aug 2, 2026	Premera Blue Cross	5.01.578 Amyotrophic Lateral Sclerosis (ALS) MedicationsPayerPolicy · PREMERA-5-01-578-AMYOTROPHIC-LATERAL-SCLEROSIS-ALS-MEDICATIONS-236FD79853	New policy
Aug 2, 2026	Premera Blue Cross	5.01.551 Use of Granulocyte Colony-Stimulating Factors (G-CSFPayerPolicy · PREMERA-5-01-551-USE-OF-GRANULOCYTE-COLONY-STIMULATING-FACTORS-G-CSF-CDEAD4AAF9	New policy
Aug 2, 2026	Premera Blue Cross	5.01.536 Nulojix (belatacept) for AdultsPayerPolicy · PREMERA-5-01-536-NULOJIX-BELATACEPT-FOR-ADULTS-F7700F5958	New policy
Aug 2, 2026	Premera Blue Cross	5.01.42 Gene Therapies for ThalassemiaPayerPolicy · PREMERA-5-01-42-GENE-THERAPIES-FOR-THALASSEMIA-0C3AE2C04D	New policy
Aug 2, 2026	Premera Blue Cross	2.04.521 Evaluation of Biomarkers for Alzheimer DiseasePayerPolicy · PREMERA-2-04-521-EVALUATION-OF-BIOMARKERS-FOR-ALZHEIMER-DISEASE-E83772A30B	New policy
Aug 2, 2026	Premera Blue Cross	2.02.517 Electrophysiology (EP) studiesPayerPolicy · PREMERA-2-02-517-ELECTROPHYSIOLOGY-EP-STUDIES-E335E7074B	New policy
Aug 2, 2026	Premera Blue Cross	1.01.17 (effective September 4, 2026) Pelvic Floor StimulationPayerPolicy · PREMERA-1-01-17-EFFECTIVE-SEPTEMBER-4-2026-PELVIC-FLOOR-STIMULATION-B9ABD69CD8	New policy
Aug 2, 2026	Premera Blue Cross	7.03.13 Composite Tissue Allotransplantation of the Hand andPayerPolicy · PREMERA-7-03-13-COMPOSITE-TISSUE-ALLOTRANSPLANTATION-OF-THE-HAND-AND-64C63D0D68	New policy
Aug 2, 2026	Premera Blue Cross	7.03.05 Small Bowel, Liver and Multivisceral TransplantPayerPolicy · PREMERA-7-03-05-SMALL-BOWEL-LIVER-AND-MULTIVISCERAL-TRANSPLANT-6E01DC7F2E	New policy
Aug 2, 2026	Premera Blue Cross	7.01.605 Shoulder Open Procedures in AdultsPayerPolicy · PREMERA-7-01-605-SHOULDER-OPEN-PROCEDURES-IN-ADULTS-D60707F43C	New policy
Aug 2, 2026	Premera Blue Cross	7.01.160 Synthetic Cartilage Implants for Joint PainPayerPolicy · PREMERA-7-01-160-SYNTHETIC-CARTILAGE-IMPLANTS-FOR-JOINT-PAIN-1F07DF6777	New policy
Aug 2, 2026	Premera Blue Cross	5.01.658 Denosumab ProductsPayerPolicy · PREMERA-5-01-658-DENOSUMAB-PRODUCTS-078868AB80	New policy
Aug 2, 2026	Premera Blue Cross	5.01.649 Pharmacologic Treatment of SeizuresPayerPolicy · PREMERA-5-01-649-PHARMACOLOGIC-TREATMENT-OF-SEIZURES-9E36683B29	New policy
Aug 2, 2026	Premera Blue Cross	5.01.623 Topical Drugs for Actinic Keratosis and Other DermatologicPayerPolicy · PREMERA-5-01-623-TOPICAL-DRUGS-FOR-ACTINIC-KERATOSIS-AND-OTHER-DERMA-DA795EE0BF	New policy
Aug 2, 2026	Premera Blue Cross	5.01.610 Pharmacologic Treatment in Assisted ReproductionPayerPolicy · PREMERA-5-01-610-PHARMACOLOGIC-TREATMENT-IN-ASSISTED-REPRODUCTION-48E4A679B4	New policy
Aug 2, 2026	Premera Blue Cross	5.01.599 Pharmacologic Treatment of Sleep DisordersPayerPolicy · PREMERA-5-01-599-PHARMACOLOGIC-TREATMENT-OF-SLEEP-DISORDERS-7DFADF1C86	New policy
Aug 2, 2026	Premera Blue Cross	5.01.585 Pharmacologic Treatment of PhenylketonuriaPayerPolicy · PREMERA-5-01-585-PHARMACOLOGIC-TREATMENT-OF-PHENYLKETONURIA-CD36133AE0	New policy
Aug 2, 2026	Premera Blue Cross	2.04.125 Proteomic Testing for Systemic Therapy in Non-SmallPayerPolicy · PREMERA-2-04-125-PROTEOMIC-TESTING-FOR-SYSTEMIC-THERAPY-IN-NON-SMALL-90173849FC	New policy
Aug 2, 2026	Premera Blue Cross	15.01.003 Thyroid Disease TestingPayerPolicy · PREMERA-15-01-003-THYROID-DISEASE-TESTING-17866AE237	New policy
Aug 2, 2026	Premera Blue Cross	1.01.29 Tumor Treating Fields TherapyPayerPolicy · PREMERA-1-01-29-TUMOR-TREATING-FIELDS-THERAPY-DD16AB7B16	New policy
Aug 2, 2026	Premera Blue Cross	8.01.544 Chimeric Antigen Receptor Therapy for Leukemia and LymphomaPayerPolicy · PREMERA-8-01-544-CHIMERIC-ANTIGEN-RECEPTOR-THERAPY-FOR-LEUKEMIA-AND-911EC8E63B	New policy
Aug 2, 2026	Premera Blue Cross	Orthoptic Training for the Treatment of Vision or Learning DisabilitiePayerPolicy · PREMERA-ORTHOPTIC-TRAINING-FOR-THE-TREATMENT-OF-VISION-OR-LEARNING-D-5C37324E62	New policy
Aug 2, 2026	Premera Blue Cross	8.01.42 Hematopoietic Cell Transplantation for Primary AmyloidosisPayerPolicy · PREMERA-8-01-42-HEMATOPOIETIC-CELL-TRANSPLANTATION-FOR-PRIMARY-AMYLO-167F83F512	New policy
Aug 2, 2026	Premera Blue Cross	7.03.07 Lung and Lobar Lung TransplantPayerPolicy · PREMERA-7-03-07-LUNG-AND-LOBAR-LUNG-TRANSPLANT-06FD7B17D9	New policy
Aug 2, 2026	Premera Blue Cross	7.01.606 Balloon Dilation of the Eustachian TubePayerPolicy · PREMERA-7-01-606-BALLOON-DILATION-OF-THE-EUSTACHIAN-TUBE-18854CDFEE	New policy
Aug 2, 2026	Premera Blue Cross	7.01.590 Shoulder ArthroplastyPayerPolicy · PREMERA-7-01-590-SHOULDER-ARTHROPLASTY-F3DE3A464C	New policy
Aug 2, 2026	Premera Blue Cross	7.01.583 Amniotic Membrane and Amniotic FluidPayerPolicy · PREMERA-7-01-583-AMNIOTIC-MEMBRANE-AND-AMNIOTIC-FLUID-EF3D252182	New policy
Aug 2, 2026	Premera Blue Cross	7.01.07 Electrical Bone Growth Stimulation of the AppendicularPayerPolicy · PREMERA-7-01-07-ELECTRICAL-BONE-GROWTH-STIMULATION-OF-THE-APPENDICUL-A52498F73D	New policy
Aug 2, 2026	Premera Blue Cross	5.01.596 Pharmacologic Treatment of OsteoporosisPayerPolicy · PREMERA-5-01-596-PHARMACOLOGIC-TREATMENT-OF-OSTEOPOROSIS-9519CF8BE5	New policy
Aug 2, 2026	Premera Blue Cross	5.01.595 Injectable Clostridial Collagenase for FibroproliferativePayerPolicy · PREMERA-5-01-595-INJECTABLE-CLOSTRIDIAL-COLLAGENASE-FOR-FIBROPROLIFE-558387159A	New policy
Aug 2, 2026	Premera Blue Cross	5.01.592 Phosphoinositide 3-kinase (PI3K) InhibitorsPayerPolicy · PREMERA-5-01-592-PHOSPHOINOSITIDE-3-KINASE-PI3K-INHIBITORS-97EFB374A5	New policy
Aug 2, 2026	Premera Blue Cross	5.01.589 BRAF and MEK InhibitorsPayerPolicy · PREMERA-5-01-589-BRAF-AND-MEK-INHIBITORS-6A58A1B526	New policy
Aug 2, 2026	Premera Blue Cross	5.01.584 CGRP Inhibitors for Migraine ProphylaxisPayerPolicy · PREMERA-5-01-584-CGRP-INHIBITORS-FOR-MIGRAINE-PROPHYLAXIS-04901392F1	New policy
Aug 2, 2026	Premera Blue Cross	5.01.576 Drugs for Rare DiseasesPayerPolicy · PREMERA-5-01-576-DRUGS-FOR-RARE-DISEASES-98C3E3D177	New policy
Aug 2, 2026	Premera Blue Cross	5.01.568 Venclexta (venetoclax) BCL-2 InhibitorPayerPolicy · PREMERA-5-01-568-VENCLEXTA-VENETOCLAX-BCL-2-INHIBITOR-D169629122	New policy
Aug 2, 2026	Premera Blue Cross	5.01.562 Imlygic (talimogene laherparepvec)PayerPolicy · PREMERA-5-01-562-IMLYGIC-TALIMOGENE-LAHERPAREPVEC-71322584CE	New policy
Aug 2, 2026	Premera Blue Cross	5.01.545 Pharmacologic Treatment of Benign Prostatic HyperplasiaPayerPolicy · PREMERA-5-01-545-PHARMACOLOGIC-TREATMENT-OF-BENIGN-PROSTATIC-HYPERPL-9F93DD15C3	New policy
Aug 2, 2026	Premera Blue Cross	5.01.539 Pharmacologic Treatment of Cystic FibrosisPayerPolicy · PREMERA-5-01-539-PHARMACOLOGIC-TREATMENT-OF-CYSTIC-FIBROSIS-2105CF2FAC	New policy
Aug 2, 2026	Premera Blue Cross	5.01.520 Antidepressants: Pharmacy Medical Necessity CriteriaPayerPolicy · PREMERA-5-01-520-ANTIDEPRESSANTS-PHARMACY-MEDICAL-NECESSITY-CRITERIA-8D3E81F2F6	New policy